275 related articles for article (PubMed ID: 16956033)
1. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
2. [Hypomania/mania induced by cessation of antidepressant drugs].
Kora K; Kaplan P
Turk Psikiyatri Derg; 2008; 19(3):329-33. PubMed ID: 18791886
[TBL] [Abstract][Full Text] [Related]
3. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
Hwang JP; Yang CH; Tsai SJ
Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
[No Abstract] [Full Text] [Related]
4. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
Liau CH; Shen WW; Su KP
Psychiatry Clin Neurosci; 2006 Feb; 60(1):121-2. PubMed ID: 16472373
[No Abstract] [Full Text] [Related]
7. Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.
Cervera-Enguix S; Baca-Baldomero E; Garcia-Calvo C; Prieto-López R;
Arch Gerontol Geriatr; 2004; 38(3):271-80. PubMed ID: 15066313
[TBL] [Abstract][Full Text] [Related]
8. Bupropion-induced hypomania in a patient with unipolar depression.
Hussain H; Butt MA
Aust N Z J Psychiatry; 2008 Aug; 42(8):746. PubMed ID: 18622783
[No Abstract] [Full Text] [Related]
9. Induction of mania in depression by paroxetine.
Morishita S; Arita S
Hum Psychopharmacol; 2003 Oct; 18(7):565-8. PubMed ID: 14533140
[TBL] [Abstract][Full Text] [Related]
10. Lithium and venlafaxine interaction: a case of serotonin syndrome.
Adan-Manes J; Novalbos J; López-Rodríguez R; Ayuso-Mateos JL; Abad-Santos F
J Clin Pharm Ther; 2006 Aug; 31(4):397-400. PubMed ID: 16882112
[TBL] [Abstract][Full Text] [Related]
11. Rapid cycling triggered by pindolol augmentation of paroxetine, but not with desipramine.
Kraus RP
Depression; 1996; 4(2):92-4. PubMed ID: 9160648
[TBL] [Abstract][Full Text] [Related]
12. Mania after venlafaxine withdrawal in a patient with generalized anxiety disorder.
Khazaal Y
Ann Pharmacother; 2007 Feb; 41(2):359-60. PubMed ID: 17284507
[No Abstract] [Full Text] [Related]
13. Venlafaxine drug-drug interactions in clinical practice.
Benazzi F
J Psychiatry Neurosci; 1998 May; 23(3):181-2. PubMed ID: 9595894
[No Abstract] [Full Text] [Related]
14. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
Vergouwen AC; Bakker A
Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
[TBL] [Abstract][Full Text] [Related]
15. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
Amsterdam JD; Shults J
J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
[TBL] [Abstract][Full Text] [Related]
17. Serotonin syndrome after lithium add-on medication to paroxetine.
Sobanski T; Bagli M; Laux G; Rao ML
Pharmacopsychiatry; 1997 May; 30(3):106-7. PubMed ID: 9211572
[TBL] [Abstract][Full Text] [Related]
18. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy.
Kopecek M; Cerná L; Sulak J; Raszka M; Bares M; Seifertová D
Neuro Endocrinol Lett; 2007 Dec; 28(6):889-94. PubMed ID: 18063943
[TBL] [Abstract][Full Text] [Related]
19. Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study.
Alevizos B; Alevizos E; Leonardou A; Zervas I
Psychiatriki; 2012; 23(2):143-8. PubMed ID: 22796912
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine efficacy and tolerability in the treatment of post-stroke depression.
Kucukalić A; Bravo-Mehmedbasić A; Kulenović AD; Suljić-Mehmedika E
Psychiatr Danub; 2007 Jun; 19(1-2):56-60. PubMed ID: 17603417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
